-
Medical journals
- Career
Computer crossmatch - performance, validation and first implementation in the Czech Republic
Authors: M. Bohoněk 1; D. Horčičková 1; M. Blažková 1; T. Lejdar 2; P. Švenda 2
Authors‘ workplace: Oddělení hematologie, biochemie a krevní transfuze, Ústřední vojenská nemocnice Praha 1; TIS Brno 2
Published in: Transfuze Hematol. dnes,12, 2006, No. 4, p. 217-222.
Category: Comprehensive Reports, Original Papers, Case Reports
Overview
The computer (electronic) crossmatch (CCM) is the method for blood compatibility screening based on correctly collected donor as well as recipient data and its safe insert to the information (computing) system. Subsequently the software by pre-set and constant pre-requisites determines the acceptable blood for transfusion or refers blood units to the serological crossmatch. The computer crossmatch in labor of Central Military Hospital Prague is the superstructure of laboratory information (computing) system for blood bank lab and ensure accomplishment of terms for blood administration with no serological crossmatching. Validation of the CCM was based on: 1. verification of general condition (i.e. data transfer), 2. performance of special designed SW tests 3. parallel performance of 150 test by serological and computer crossmatch. The CCM we implemented routinely since August 1, 2005 and actually we use it in 85% cases. The method saves time and costs significantly.
Key words:
computer crossmatch, electronic crossmatch, computer crossmatching
Labels
Haematology Internal medicine Clinical oncology
Article was published inTransfusion and Haematology Today
2006 Issue 4-
All articles in this issue
- Quality parameters of cryopreserved red cells reconstituted in AS-3 solution (Nutricel)
- Computer crossmatch - performance, validation and first implementation in the Czech Republic
- Indications of allogeneic and autologous haematopoietic cells transplantations. Recommendations of the Czech Socienty of Haematology and Czech Society of Oncology of the J. E. Purkyně Czech Medical Association
- The risk factors analysis in 248 patients with B-cell chronic lymphocytic leukemia at diagnosis
- Significance of immunotherapy with anti-CD20 rituximab and high-dose chemotherapy with autologous peripheral blood stem-cell transplantation in first-line treatment for mantle-cell lymphoma – centre experience
- Evaluation of antigen-specific lymphocytes anti-tumour effect with use of non-radioactive cytotoxicity test
- B-cell chronic lymphocytic leukemia Part III: Current conventional options of first-line treatment
- Transfusion and Haematology Today
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue- Computer crossmatch - performance, validation and first implementation in the Czech Republic
- Significance of immunotherapy with anti-CD20 rituximab and high-dose chemotherapy with autologous peripheral blood stem-cell transplantation in first-line treatment for mantle-cell lymphoma – centre experience
- Quality parameters of cryopreserved red cells reconstituted in AS-3 solution (Nutricel)
- Evaluation of antigen-specific lymphocytes anti-tumour effect with use of non-radioactive cytotoxicity test
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career